The Distribution and Antibacterial Activity of Marine Sponge-Associated Bacteria in the Aegean Sea and the Sea of Marmara, Turkey

Study of marine microorganism metabolites: new resources for bioactive natural products

The marine environment has remained a source of novel biological molecules with diversified applications. The ecological and biological diversity, along with a unique physical environment, have provided the evolutionary advantage to the plant, animals and microbial species thriving in the marine ecosystem. In light of the fact that marine microorganisms frequently interact symbiotically or mutualistically with higher species including corals, fish, sponges, and algae, this paper intends to examine the potential of marine microorganisms as a niche for marine bacteria. This review aims to analyze and summarize modern literature data on the biotechnological potential of marine fungi and bacteria as producers of a wide range of practically valuable products (surfactants, glyco-and lipopeptides, exopolysaccharides, enzymes, and metabolites with different biological activities: antimicrobial, antitumor, and cytotoxic). Hence, the study on bioactive secondary metabolites from marine microorganisms is the need of the hour. The scientific novelty of the study lies in the fact that for the first time, the data on new resources for obtaining biologically active natural products - metabolites of marine bacteria and fungi - were generalized. The review investigates the various kinds of natural products derived from marine microorganisms, specifically focusing on marine bacteria and fungi as a valuable source for new natural products. It provides a summary of the data regarding the antibacterial, antimalarial, anticarcinogenic, antibiofilm, and anti-inflammatory effects demonstrated by marine microorganisms. There is currently a great need for scientific and applied research on bioactive secondary metabolites of marine microorganisms from the standpoint of human and animal health.

Inactivation of E. coli and Streptococcus agalactiae by UV/persulfate during marine aquaculture disinfection

Sulfate radical (•SO₄^-)-based advanced oxidation processes have attracted a great deal of attention for use in water disinfection because of their strong oxidation ability toward electron-rich moieties on microorganism molecules. However, a few studies have focused on the effects of •SO₄^- on pathogenic microorganism inactivation in marine aquaculture water containing various inorganic anions. We employed the gram-negative bacteria E. coli and gram-positive bacteria S. agalactiae as representatives to evaluate the application of UV/persulfate (S₂O₈^2-, PDS), to the disinfection of marine aquaculture water in a comprehensive manner. Total inactivation of 4.13ˍlog of E. coli cells and 4.74ˍlog of S. agalactiae cells was reached within 120 s in the UV/PDS system. The inactivation of pathogenic bacteria in marine aquaculture water increased with the increasing PDS concentration and UV intensity. An acidic pH was beneficial for UV/PDS inactivation. Halogen-free radicals showed a strong influence on the inactivation. Anions in seawater, including Cl^-, Br^-, and HCO₃^- inhibited the disinfection. The inactivation rates of pathogenic bacteria followed the order seawater < marine aquaculture water < freshwater. Pathogenic bacteria could also be effectively inactivated in actual marine aquaculture water and reservoir water. The analysis of the inactivation mechanisms showed that S₂O₈^2- was activated by UV to produce •SO₄^-, which damaged the cell membranes. In addition, antioxidant enzymes, including SOD and CAT, were induced. The genomic DNA was also damaged. Inorganic disinfection byproducts such as chlorate and bromate were not formed during the disinfection of marine aquaculture water, which indicated that UV/PDS was a safe and efficient disinfection method.

Pharmacological Activities of Extracts and Compounds Isolated from Mediterranean Sponge Sources

Marine pharmacology is an exciting and growing discipline that blends blue biotechnology and natural compound pharmacology together. Several sea-derived compounds that are approved on the pharmaceutical market were discovered in sponges, marine organisms that are particularly rich in bioactive metabolites. This paper was specifically aimed at reviewing the pharmacological activities of extracts or purified compounds from marine sponges that were collected in the Mediterranean Sea, one of the most biodiverse marine habitats, filling the gap in the literature about the research of natural products from this geographical area. Findings regarding different Mediterranean sponge species were individuated, reporting consistent evidence of efficacy mainly against cancer, infections, inflammatory, and neurological disorders. The sustainable exploitation of Mediterranean sponges as pharmaceutical sources is strongly encouraged to discover new compounds.

Marine Bacterial Secondary Metabolites: A Treasure House for Structurally Unique and Effective Antimicrobial Compounds

The prevalence of antimicrobial resistance reduces the effectiveness of antimicrobial drugs in preventing and treating infectious diseases caused by pathogenic organisms, such as bacteria, fungi, and viruses. Because of the burgeoning growth of microbes with antimicrobial-resistant traits, there is a dire need to identify and develop novel and effective antimicrobial agents to treat infections from antimicrobial-resistant strains. The marine environment is rich in ecological biodiversity and can be regarded as an untapped resource for prospecting novel bioactive compounds. Therefore, exploring the marine environment for antimicrobial agents plays a significant role in drug development and biomedical research. Several earlier scientific investigations have proven that bacterial diversity in the marine environment represents an emerging source of structurally unique and novel antimicrobial agents. There are several reports on marine bacterial secondary metabolites, and many are pharmacologically significant and have enormous promise for developing effective antimicrobial drugs to combat microbial infections in drug-resistant pathogens. In this review, we attempt to summarize published articles from the last twenty-five years (1996–2020) on antimicrobial secondary metabolites from marine bacteria evolved in marine environments, such as marine sediment, water, fauna, and flora.